Mohamed Wa’el Ahmed Hashad
Chief Executive Officer bij LONGEVERON INC.
Vermogen: 63 752 $ op 31-03-2024
Profiel
Mohamed Wa’el Ahmed Hashad is currently the Chief Executive Officer & Director at Longeveron, Inc., an Independent Director at Akari Therapeutics Plc, and a Director at California Life Sciences Association.
Previously, he served as the President & Chief Executive Officer at Avanir Pharmaceuticals, Inc. from 2020 to 2023 and as the Chief Commercial Officer & Executive VP at Seres Therapeutics, Inc. from 2016 to 2017.
He holds an undergraduate degree from the University of Pennsylvania, an MBA from the University of Akron, and another undergraduate degree from the University of Cairo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LONGEVERON INC. CLASS A
1.91% | 11-04-2024 | 19 616 ( 1.91% ) | 63 752 $ | 31-03-2024 |
Actieve functies van Mohamed Wa’el Ahmed Hashad
| Bedrijven | Functie | Begin |
|---|---|---|
| LONGEVERON INC. | Chief Executive Officer | 01-03-2023 |
| AKARI THERAPEUTICS, PLC | Director/Board Member | 05-07-2023 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | - |
Eerdere bekende functies van Mohamed Wa’el Ahmed Hashad
| Bedrijven | Functie | Einde |
|---|---|---|
| AVANIR PHARMACEUTICALS INC | Chief Executive Officer | 01-01-2023 |
| SERES THERAPEUTICS, INC. | Corporate Officer/Principal | 21-06-2017 |
Opleiding van Mohamed Wa’el Ahmed Hashad
| University of Pennsylvania | Undergraduate Degree |
| University of Akron | Masters Business Admin |
| University of Cairo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| AKARI THERAPEUTICS, PLC | Health Technology |
| LONGEVERON INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
